Innate Pharma
IPHA
#8402
Rank
โ‚น14.96 B
Marketcap
โ‚น174.89
Share price
0.50%
Change (1 day)
-18.80%
Change (1 year)

EPS for Innate Pharma (IPHA)

EPS in 2022: -โ‚น68.03

According to Innate Pharma 's latest financial reports the company's current EPS (TTM) is -โ‚น68.03. In 2022 the company made an earnings per share (EPS) of -โ‚น68.03 a decrease over its 2021 EPS that were of -โ‚น65.04.

EPS history for Innate Pharma from 2005 to 2022

Annual EPS

Year EPS Change
2022-โ‚น68.034.6%
2021-โ‚น65.04-24.98%
2020-โ‚น86.69186.89%
2019-โ‚น30.22-707.12%
2018โ‚น4.98-105.35%
2017-โ‚น92.96-541.28%
2016โ‚น21.07-270.34%
2015-โ‚น12.37-70.03%
2014-โ‚น41.27390.66%
2013-โ‚น8.41-8.65%
2012-โ‚น9.21-57.03%
2011-โ‚น21.43-48.58%
2010-โ‚น41.66-40.32%
2009-โ‚น69.8124.76%
2008-โ‚น55.9522.34%
2007-โ‚น45.7416.95%
2006-โ‚น39.11-7.23%
2005-โ‚น42.16